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Background: Neointimal formation plays an important role in the pathogenesis of coronary restenosis after
percutaneous coronary intervention (PCI), especially in patients with diabetes mellitus. Recently, some
studies have shown that 5-ethynyl-2'-deoxyuridine (EdU) incorporation can serve as a novel alternative to
the 5-bromo-2'-deoxyuridine (BrdU) antibody detection method for detection of DNA synthesis in regenerating
avian cochlea, chick embryo and the adult nervous system. However, few studies have been performed to
assess the suitability of EdU for detecting DNA synthesis in vascular neointima.
Methods: The carotid artery balloon injury model was established in Goto-Kakizaki (GK) and Wistar rats.
A Cell-LightTM EdU Kit was used to detect EdU-labeled cell nuclei of common carotid arteries at day 7 after catheter
balloon injury. Different methods of injecting EdU were tested. The protein levels of proliferating cell nuclear
antigen (PCNA) and p-Akt (Ser473), as well as the mRNA levels of PCNA were evaluated by Western blotting and
quantitative real-time PCR (qRT-PCR), respectively. Immunohistochemical staining was also employed to visualize
PCNA-positive cells.
Results: At day 7 after catheter balloon injury, far more EdU-positive and PCNA-positive cells were observed in GK
rats. When comparing groups that received different EdU doses, it was found that the percentage of EdU-positive
cells at a dose of 100 mg/kg body weight was than at doses of 25 mg/kg and 50 mg/kg. The number of positive
cells was significantly higher in the repeated injection group compared to the single injection group. Further,
after balloon injury DNA synthesis in GK rats was more notable than in Wistar rats. Neointimal formation in GK
rats was more obvious than in Wistar rats. The protein levels of PCNA and p-Akt (Ser473) and the mRNA levels of
PCNA were increased in injured rats as compared to uninjured rats, and were significantly higher in GK rats than
in Wistar rats.
Conclusion: By intraperitoneal injections of EdU at a dose of 100 mg/kg three times, EdU incorporation can detect
carotid arterial DNA synthesis caused by neointimal formation in GK rats and Wistar rats at day 7 after balloon injury
by the EdU click reaction quickly and effectively. Moreover, more obvious DNA synthesis in the vascular neointima
could be observed in GK rats than in Wistar rats.
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Coronary artery disease (CAD) is the leading cause of
death among both men and women in China and west-
ern industrialized nations. Diabetes mellitus is the single
worst risk factor for CAD. CAD in diabetic patients is
diffuse, severe, presents with more complex lesions and
often progresses rapidly. Restenosis remains the major
limitation for long-term success after percutaneous cor-
onary intervention (PCI) even in the drug eluting stent
era, especially in patients with diabetes mellitus [1,2].
Angiographic restenosis rates of 15.2% have been
demonstrated following successful drug-eluting stenting
among patients with diabetes in a study in Germany [3].
Drug eluting stents are considered by many to be the
standard of care for patients with diabetes undergoing
PCI; however, analysis of diabetic subgroup in the SIR-
IUS (SIRolImUS-coated Bx Velocity balloon-expandable
stent in the treatment of patients with de novo coronary
artery lesions) trial demonstrated that absolute late loss
of lumen and restenosis remains higher in patients with
diabetes receiving stents eluting sirolimus (also known
as rapamycin, an immunosuppressive agent) [4]. TAXUS
(a brand of stent) trials showed similar results, in which
the slow rate-release polymer-based stents eluting pacli-
taxel (an antineoplastic agent) were employed [5].
Sheehy et al. found that the use of paclitaxel-eluting
stents resulted in greater neointimal area and increased
inflammation compared to everolimus-eluting stents [6].
Thus, it is clear that the occurrence of restenosis still
remains inevitable regardless which drug-eluting stent is
employed. Generally, restenosis is the result of early
elastic recoil, adverse remodeling, and the formation of
neointimal after angioplasty or stenting. Additionally,
vascular smooth muscle cell (VSMC) proliferation is one
of major mechanisms of neointimal formation. Some
studies have been conducted to investigate the molecular
mechanism by which it occurs [7,8] and have tried to
suppress neointimal formation by attenuating VSMC
proliferation [9]. Therefore, observation of VSMCs pro-
liferation and neointimal formation is an important
method for studying restenosis after vascular injury.
Detecting DNA synthesis in the vascular wall can indir-
ectly reflect the VSMC proliferation in vivo.
Five-ethynyl-2'-deoxyuridine (EdU) is a nucleoside
analog of thymidine which can be incorporated into
DNA during active DNA synthesis. It is considered to be
a novel alternative for 5-bromo-2'-deoxyuridine (BrdU)
to measure DNA synthesis or S-phase synthesis of the
cell cycle [10,11]. BrdU staining requires harsh DNA de-
naturation (HCl, digestion with DNase or heat) to ex-
pose BrdU for detection with an anti-BrdU antibody and
this action can destroy the tissue’s structures. In marked
contrast, detection of EdU is based on a copper (I) cata-
lyzed reaction [12,13] between an azide and an alkyne,and this reaction is considerably faster. Using an azide-
containing detection reagent to react with the alkyne
contained in EdU can form a stable triazole ring. More-
over, the azide-containing detection reagent is signifi-
cantly smaller than a BrdU antibody, so it can penetrate
into a double-stranded DNA easily and can react with
incorporated EdU without denaturation of the DNA.
The advantage of a “click” reaction is that it makes it
more convenient to observe DNA synthesis in vitro [14-
17] and allows for a simple, fast protocol which pro-
duces more reproducible and reliable results. The “click”
reaction involves the coupling of an azide-labeled com-
pound and a terminal alkyne-labeled compound in the
presence of copper (I) to form a stable covalent triazole
ring conjugate [11]. At the same time, some recent stud-
ies have shown that EdU can also be used to observe
DNA synthesis in vivo [18-21].
A common factor in the pathogenesis restenosis after
PTCA (Percutaneous transluminal coronary angioplasty)
and PCI is neointimal formation, which appears follow-
ing catheter balloon injury. In our previous studies, we
used the carotid artery balloon injury model in obese
Zucker rats, a well-established model of type II diabetes
mellitus (T2DM) [22], as well as lean Zucker rats, to in-
vestigate the vascular response to balloon injury in dia-
betes [23-25]. Our studies demonstrated that this model
is still valuable for investigating the mechanism of
neointimal formation. Moreover, we have observed
neointimal formation using the BrdU antibody detection
method [24,26]. We found that the number of BrdU-
positive cells in obese Zucker rats after balloon injury
was more apparent than in lean Zucker rats. However,
few studies have been done on whether EdU can be used
to detect DNA synthesis of neointimal formation. The
Zucker obese rat and Goto-kakizaki (GK) rat are both
established rat models of T2DM. The GK rat model was
developed by selectively breeding non-diabetic Wistar
rats for glucose intolerance over multiple generations
[27]. Compared with Zucker obese rats, GK rats are also
characterized by hyperinsulinemia and mild hypergly-
cemia but are not obese, and have a stable and inherit-
able form of T2DM [28]. And the use of GK rats is
more cost-effective due to the fact that their traits are
dominant. The aim of the present study is to examine
whether EdU incorporation can detect DNA synthesis in
the vascular neointima of GK rats and Wistar rats after




Male GK rats and male Wistar rats (weight, average 380 g)
were used as a diabetic group and a non-diabetic
group, respectively. Animals were divided into four
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Wistar control. Nine rats were selected in each group.
All animals and forage were purchased from SLAC
Laboratory Animal Limited Company, Shanghai. GK
rats were fed with a high fat diet and Wistar rats with a
normal diet. Drink and food were given randomly. The
room temperature was maintained at 23 to 25 degrees
Celsius,with 50%-60% humidity and eight hours of light
per day. All experiments were approved by the Animal
Research Committee of Xuzhou Medical College
(permit number XMCACUC2010-08-114).
Carotid artery balloon injury model in rats
All rats were anesthetized by intraperitoneal injection of
10% chloral hydrate (3 ml/kg body wt) diluted in double
distilled water. Surgical procedures were performed by
sterile surgical technique. A midline cervical incision
was made to expose the left external carotid artery by
blunt dissection. A 2F Fogarty balloon catheter (Edwards
Lifescience Corp) was introduced from the external
carotid artery into the aortic arch after the distal end of
the external carotid artery was ligated. The balloon was
distended with saline until a slight resistance was felt on
slight traction. The balloon was gently rotated and with-
drawn into the common carotid artery, then pulled back
into the external carotid artery. After this procedure was
repeated 3 times, the proximal end was ligated to the ex-
ternal carotid artery. At day 7 after balloon injury, the
left common carotid arteries were completely exposed
and removed after rats were euthanized by intraperito-
neal injection with 10% chloral hydrate. Harvested arter-
ies were flushed rapidly with ice-cold phosphate buffer
saline (PBS). These specimens were stored in 4% paraf-
ormaldehyde diluted in PBS for 24 to 48 hours before
paraffin embedding or frozen in negative 86 degrees
freezer (Thermo Scientific Forma ULT).
EdU staining
EdU staining was conducted using Cell-LightTM EdU Kit
(Rui Bo Guangzhou Biotechnology Limited Company,
China), according to the manufacturer’s protocol. Paraf-
fin sections were de-paraffinated in xylene for 10 min
twice, a gradient of alcohol (100%, 95%, 85%) for 10 min,
and were rinsed in deionized water for 5 min. After
washing with 2 mg/ml glycine solution diluted in double
distilled water for 10 min, the sections were permea-
blized with 0.5% Triton X-100 in PBS for 20 min, and
then washed twice with PBS for 10 min each rinse. The
Apollo reaction buffer liquid, catalyst, fluorescent dyes
and buffer additives were dissolved in deionized water,
and shaken to make the ApolloW 567 staining reaction
solution. The sections were then incubated for 30 min
without light. The sections were washed twice with PBS
for 10 min each rinse. For subsequent DNA staining,sections were counterstained with Hoechst 33342 for 30
min away from light. The slides were then washed twice
with PBS for 3 min each rinse, and observed immedi-
ately under a fluorescent microscope (magnification
×400). All the procedures were conducted at room
temperature. An Olympus BX51 microscope (Olympus,
Japan) was used to observe EdU-positive cells. Images of
the ApolloW 567 were captured with a “red” filter set:
Excitation: 550nm, Emission: 565nm, Filter: 555±15nm.
Images of the Hoechst 33342 were captured with a
“blue” filter set: Excitation: 350nm, Emission: 461nm,
Filter: 405±15nm.
Quantitative real-time PCR (qRT-PCR)
Total RNA was isolated from common carotid artery of
Wistar and GK injury and control, using TRIzolW Re-
agent (Invitrogen life technologies) according to the
manufacturer's instructions. Two micrograms of total
RNA was then used for reverse transcription reaction
using MMLV reverse transcriptase (Epicentre, Madison,
WI). qRT-PCR was performed in an ABI PRISM7900
system (Applied Biosystems, Foster City, CA). And the
gene expression of proliferating cell nuclear antigens
(PCNA) and GAPDH was examined by 2×PCR master
mix (Superarray). The reaction protocol included prein-
cubation at 95°C to activate Taq DNA polymerase for 10
min, amplification of 40 cycles that was set for 10 s at
95°C, and annealing for 60 s at 60°C. The results were
normalized with the housekeeping gene rat GADPH.
Primer sequences were designed using software Primer
5.0 as follows. Rat PCNA forward, 5’TGAAGTTT
TCTGCGAGTGGG3’; rat PCNA reverse, 5’CAGTG
GAGTGGCTTTTGTGAA3’; rat GADPH forward, 5’GG
AAAGCTGTGGCGTGAT-3’; rat GADPH reverse, 5’AA
GGTGGAAGAATGGGAGTT3’.
Western blot analysis
The frozen common carotid tissue was homogenized in
100ul of ice-cold RIPA Lysis Buffer including 1μL PMSF
(100 mM) (Beyotime Institute of Biotechnology, China)
and then incubated on ice for 30 min. Samples were
centrifuged at 12,000g for 10 min at 4°C. The super-
natant was collected and measured for total protein con-
tent using the BCA Protein Assay kit (Beyotime Institute
of Biotechnology, China). 20 μg total lysate was run on
SDS-polyacrylamide gel electrophoresis and transferred
onto Polyvinylidene Fluoride (PVDF) membranes. Mem-
branes were blocked in TBST buffer containing 5% Difco
TM Skim Milk (BD 232100) and incubated with the pri-
mary antibodies PCNA, Akt and p-Akt (Ser 473) (Cell
Signaling Technology). Secondary antibodies were
horseradish peroxidase (HRP) labeled Goat Anti-Mouse
IgG (H+L), and detection was performed using
enhanced chemiluminescence (ECL) (Beyotime Institute
Figure 1 Representative images of EdU staining by different EdU injection methods (magnification ×400). (A) Three intraperitoneal
injections of EdU at day 7 after balloon injury (a-l): (a, c, e) EdU staining for Wistar rats at a dose of 5 mg/kg, 25 mg/kg and 50 mg/kg in
sequence; (b, d, f) EdU staining for GK rats at a dose of 5 mg/kg, 25 mg/kg and 50 mg/kg in sequence; (g-j) Hoechst 33342 and EdU staining for
Wistar and GK rats at a dose of 100 mg/kg in order; (k, l) EdU staining for Wistar and GK rats at a dose of 200 mg/kg, respectively. (m, n) EdU
staining for uninjuried Wistar and GK rats at a dose of 100 mg/kg, respectively. (o, p) Hoechst 33342 and EdU staining for GK rats at a single
injection of 100 mg/kg, respectively. (B) Line charts depicting the dose dependence of EdU staining. (C) Bar diagrams showing the increased
number of EdU-positive cells was more significant in the injury groups than in the uninjured groups for Wistar and GK rats at a dose of 100 mg/
kg, respectively. (D) Bar diagrams showing a greater number of EdU-positive cells were observed using multiple injections than a single one.
Arrows in images sign EdU-labeled cells and lums indicate luminal side of artery. * indicates Wistar control versus Wistar day 7, # indicates GK
control versus GK day 7, $ indicates Wistar day 7 versus GK day 7. p<0.01.
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Figure 2 qRT-PCR of PCNA from common carotid arteries in
both GK and Wistar rats. The fold change was calculated
compared with the expression of Wistar control group (set as
value 1). Data represent the mean±SD, and the experiment was
repeated three times. * indicates Wistar control versus Wistar day 7,
# indicates GK control versus GK day 7, $ indicates Wistar day 7
versus GK day 7. p<0.05.
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were performed using Image J for Windows software
(National Institutes of Health). Each experiment was
repeated three times.
Immunohistochemistry for PCNA
Immunohistochemistry was performed using mouse
monoclonal antibody to (Cell Signaling Technology)
PCNA as the first antibody. SP (Streptavidin-Peroxidase)
immunohistochemical assay Kit (Zhongshan Golden-
bridge Biotechnology CO. LTD) was used during the
staining procedure according to the manufacturer’s
protocol.
Morphometry and histopathology
The arterial segments were embedded in paraffin. Sec-
tions (3~5 μm thick) were de-paraffinated and under-
went hematoxylin-eosin (H&E) staining and Elastic Van
Gieson (E.V.G) staining. Histomorphometric analysis
was performed by individuals blinded to the treatment
mode. The ratio of neointimal to medial area (N/M) was
calculated using Image Pro Plus 3.0 (Media Cybernetics
Corporation)
Blood glucose and lipid levels
At the time of euthanasia, blood samples were collected
by cardiac puncture. Serum glucose levels, total choles-
terol, HDL cholesterol, LDL cholesterol and triglycerides
were measured by the enzymatic method analysis.
Statistical analysis
Quantitative data were expressed as mean±SD. Statistical
analyses was performed with the use of GraphPad Prism
5.0 (GraphPad Software Inc). Continuous variables were
compared using student t tests. A value of p<0.05 was
considered to be statistically significant.
Results
EdU staining for DNA synthesis
The percentage of EdU-positive cells in GK and Wistar
rats using different doses of EdU was studied. EdU dis-
solved in PBS was injected intraperitoneally into Wistar
and GK rats using the following doses: 5, 25, 50, 100
and 200 mg/kg at hours 18, 12 and 2 before the euthan-
asia. Common carotid arteries were harvested for fix-
ation and embedding. EdU staining was then conducted
according to the manufacturer’s protocol. Few EdU-
positive cells were observed in Wistar and GK rats at a
dose of 5 mg/kg and 25 mg/kg (Figure 1A. a-d). A few
EdU-positive cells were seen in Wistar and GK rats at a
dose of 50 mg/kg (Figure 1A. e-f ). Prominent EdU-
positive cells were observed in Wistar and GK rats at a
dose of 100 mg/kg and 200 mg/kg, respectively
(Figure 1A. g-l). As shown in Figure 1B, the dosedependence of EdU staining was found and using 100
mg/kg met the basic saturated EdU staining result. And
the increased number of positive cells were found in the
injury group than in the control group at a dose of 100
mg/kg for both groups: GK rats (42.67±3.07% versus
1.42±0.42%, p<0.01) and Wistar rats (21.67±1.76% versus
1.15±0.38%, p<0.01); the percentage was higher in GK
rats (p<0.01) (Figure 1A. g-j, m-n, and C).
Whether a single injection could achieve the same re-
sult was also studied. First, EdU was injected intraperito-
neally (100 mg/kg) into injured GK rats at hours 4
before euthanasia. Second, EdU was injected intraperito-
neally (100 mg/kg) three times at hours 18, 12 and 2 be-
fore the euthanasia. The common carotid arteries were
harvested and EdU staining was conducted as described
above. A greater number of EdU-positive cells were
observed using multiple injections than a single one
(p<0.01) (Figure 1A. i-j, o-p and D).
qRT-PCR analysis of PCNA mRNA expression
In order to further validate the cell proliferation at the
level of gene expression, balloon injury-induced gene
transcription of PCNA was examined by qRT-PCR. As
shown in Figure 2, PCNA expression was markedly up-
regulated at day 7 after balloon injury in Wistar rats
(1.35±0.05-fold versus 1.00±0.06-fold, p<0.05) and GK
rats (1.82±0.11-fold versus 1.02±0.05-fold, p<0.05), and
was significantly higher in injured GK arteries than in
injured Wistar arteries (p<0.05). There was no signifi-
cant difference found between the uninjured arteries of
GK and Wistar rats (p>0.05).
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PCNA and p-Akt levels were measured in Wistar and GK
rat arteries after injury and in controls by Western blot-
ting. The results, shown in Figure 3, demonstrate a basal
level of PCNA and p-Akt protein expression exists in
uninjured rats, but an increase in expression occurs in
response to endothelial injury. Western blot analysis
revealed that PCNA expression increased both in GK rats
(85.67±6.74% versus 6.00±1.16%, p<0.01) and in Wistar
rats (45.33±6.12% versus 5.67±0.88%, p<0.01) after bal-
loon injury, and the increase in the former was more sig-
nificant than the latter (p<0.01). The phosphorylation
level of Akt, which was expressed at the ratio of p-Akt to
Akt, which was significantly higher in GK rats after bal-
loon injury (99.67±3.28% versus 16.00±2.31%, p<0.01)
than was observed in Wistar rats (53.67±4.91% versus
13.67±2.03%, p<0.01). There was no significant differenceFigure 3 Balloon injury-induced activation of PCNA and p-Akt in com
and p-Akt in GK and Wistar rats at day 7 after balloon injury and control gr
after normalization to β-actin. (C) Bar diagrams showing the ratio of p-Akt
versus Wistar day 7, # indicates GK control versus GK day 7, $ indicates Wisfound between the GK and Wistar control groups in the
levels of either PCNA or p-Akt/Akt (p>0.05).
PCNA Immunohistochemical analysis
PCNA monoclonal antibody was used for immunohisto-
chemical staining in GK and Wistar rats before and after
carotid artery injury for both groups. PCNA-positive
cells increased significantly in common carotid arteries
at day 7 after balloon injury than before the injury in GK
(37.67±1.99% versus 1.83±0.31%, p<0.01) and in Wistar
rats (21.00±2.21% versus 1.67±0.33%, p<0.01). PCNA
positive cells in GK rats were more than those in Wistar
rats (p<0.01) (Figure 4).
Morphology and histopathology analysis
The common carotid arteries were harvested for H&E
and E.V.G staining at day 7 after balloon injury. Moremon carotid arteries. (A) Representative Western blot for PCNA, Akt
oups. (B) Bar diagrams depicting the relative protein level of PCNA
to Akt. Data represent the mean±SD, n=3. * indicates Wistar control
tar day 7 versus GK day 7. p<0.01.
Figure 4 Representative immunohistochemical photomicrographs for PCNA expression in common carotid arteries (magnification
×400). (A) Wistar rats control. (B) A large number of PCNA positive cells were observed in Wistar rats at day 7 after balloon injury. (C) GK rats
control. (D) Strong PCNA immunostaining was seen in GK rats at day 7 after balloon injury. (E) The percentage of PCNA positive cells in
Wistar and GK rats after balloon injury increased significantly as compared to Wistar and GK rats control respectively. The percentage of PCNA
positive cells in Wistar rats was significantly less than in GK rats. Arrows in images sign PCNA positive cells and lums indicate luminal side of
artery. * indicates Wistar control versus Wistar day 7, # indicates GK control versus GK day 7, $ indicates Wistar day 7 versus GK day 7. p<0.01.
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mon carotid arteries of GK rats after balloon injury than
before the injury (36.00±2.48% versus 1.15±0.41%,
p<0.01). The same result can also be observed in injured
Wistar rats (9.00±1.42% versus 1.28±0.42, p<0.01). At
the same time, neointimal formation after balloon injury
in GK rats were compared to that in Wistar rats. More
visible neointimal formation could be observed in
injured GK rats than in injured Wistar rats (p<0.01)
(Figure 5 and Figure 6).Figure 5 Morphological changes of rat common carotid arteries by H
(B) Neointimal formation was seen in Wistar rats at day 7 after balloon inju
in GK rats at day 7 after balloon injury. (E) The degree of neointimal hyperp
increased significantly as compared to Wistar and GK rats control, respectiv
in images sign neointimal formation after balloon injury. * indicates Wistar
$ indicates Wistar day 7 versus GK day 7. p<0.01.Blood biochemistry test
The level of serum glucose, total cholesterol, HDL chol-
esterol, LDL cholesterol and triglycerides in GK rats and
Wistar rats was measured and is shown in Table 1.
Discussion
T2DM, a disease of carbohydrate metabolism, should be
considered a vascular disease because diabetic patients
have higher incidence of atherosclerosis [29]. Metabolic
and hematologic abnormalities exist in T2DM, including&E staining method (magnification ×200). (A) Wistar rats control.
ry. (C) GK rats control. (D) Visible neointimal formation was observed
lasia expressed by N/M in Wistar and GK rats after balloon injury
ely. N/M in GK rats was significantly higher than in Wistar rats. Arrows
control versus Wistar day 7, # indicates GK control versus GK day 7,
Figure 6 Morphological changes of rat common carotid arteries by E.V.G staining method (magnification ×200). (A) Wistar rats control.
(B) Neointimal formation was seen in Wistar rats at day 7 after balloon injury. (C) GK rats control. (D) Visible neointimal formation was observed
in GK rats at day 7 after balloon injury. (E) The degree of neointimal hyperplasia expressed by N/M in Wistar and GK rats after balloon injury
increased significantly as compared to Wistar and GK rats control, respectively. N/M in GK rats was significantly higher than in Wistar rats.
Arrows in images sign neointimal formation after balloon injury. * indicates Wistar control versus Wistar day 7, # indicates GK control versus GK
day 7, $ indicates Wistar day 7 versus GK day 7. p<0.01.
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mation, and thrombophilia [30]. Diabetes itself is an in-
dependent risk factor for cardiovascular events. T2DM
increases the risk for CAD by 2 to 4 times that of the
overall population [31]. CAD is more ubiquitous and
has a worse prognosis in adults with diabetes mellitus
than non-diabetic patients [32]. Restenosis in patients
undergoing PCI results in a lowered long term survival
rate and increased rates of repeat revascularization [33].
Moreover, the likelihood of target vessel revasculariza-
tion in patients with diabetes mellitus after PCI is
increased [34]. A serial intravascular ultrasound study
showed that neointimal formation was closely related to
diabetes mellitus restenosis after vascular injury [35].
The tagging of newly synthesized DNA in cells or
tissues to identify proliferation is an important experi-
mental technique. [3H]Thymidine has been quite useful
for studying DNA replication and assessing cell prolif-
eration. However, the procedure is burdensome. BrdU
staining was believed to be the “gold standard” method
for detecting DNA synthesis. However, detection ofTable 1 Serum glucose and lipids levels of GK and Wistar
rats after injury
Serum GK rats(n=9) Wistar rats(n=9) p-value
GLU (mmol/L) 18.96±0.74 12.01±0.58 <0.001
CHO (mmol/L) 2.81±0.20 1.23±0.06 <0.001
LDL-C (mmol/L) 1.59±0.05 0.65±0.05 <0.001
HDL-C (mmol/L) 0.95±0.05 0.45±0.03 <0.001
TG (mmol/L) 0.94±0.03 1.04±0.22 >0.05
GLU, serum glucose level; CHO, total cholesterol; LDL-C, low density
lipoprotein cholesterol; HDL-C, high density lipoprotein cholesterol.BrdU requires DNA denaturation of the specimen which
makes the staining process difficult and penetration of
BrdU-antibody through fixed tissue is comparatively dif-
ficult. Recently, the use of EdU has been described to
detect DNA replication in vivo and in vitro in animals.
The application of EdU was also reported in plants and
fission yeast [36,37]. Grenier et al. determined the
impact of paternal exposure to cyclophosphamide, an
anticancer alkylating agent, on the formation, chromatin
origin, and function of micronuclei in cleavage stage rat
embryos using EdU incorporation to monitor DNA syn-
thesis [38]. In addition, Škalamera et al. transferred
protein-coding human open reading frames (ORFs) from
the Mammalian Gene Collection into lentiviral expres-
sion vector using the highly efficient Gateway recombin-
ation cloning and labeled transduced cells with EdU to
detect cells progressing through S phase [39]. The full
potential of EdU in biomedical research remains to be
explored.
Carotid artery injury was induced by balloon de-
endothelialization in our previous study. Cell prolifera-
tion in obese Zucker rats was higher than in lean Zucker
rats at day 7 after injury, and the neointimal area of
obese Zucker rats was also broader than that of lean
Zucker rats at day 7 after injury [26]. Since Zucker rats
and GK rats performed the same in this research. GK
rats were used for some of the following research to re-
place Zucker rats. Time course of neointimal formation
in our study was in agreement with experiments per-
formed in our previous study [26]. We have evaluated
the effect of rosiglitazone on VSMCs proliferation in
Zucker obese and lean rats after carotid artery injury
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thesis in vivo. The rats received intraperitoneal injections
of 50 mg/kg BrdU at hours 18, 12 and 2 before euthan-
asia. Following this procedure, the number of BrdU-
labeled positive cells in the intima and media was
counted [23]. In the present day, GK and Wistar rats on
the 7th day after injury were chosen to detect EdU-
labeled DNA synthesis of neointimal formation and for
making morphological comparisons. In the current
study, we report the use of EdU to conveniently and
quickly detect DNA synthesis of neointimal formation in
rats after injury. EdU was injected into model rats at dif-
ferent doses and different injection frequencies to reach
an optimal injection method for staining. Better staining
results were obtained with multiple EdU injections of
100 mg/kg. This may be related to the fact that more
EdU can be incorporated into proliferating cells during
DNA synthesis of neointimal formation than a single in-
jection or low doses. Attempts to obtain higher fluores-
cence intensity and more positive cells by injecting EdU
at 200 mg/kg were unsuccessful. Along with enhance-
ment in fluorescence intensity of EdU positive cells, the
brightness of the background was simultaneously
increased; however, the actual percentage of EdU posi-
tive cells remained almost the same.
PI3K/Akt signaling plays a key role in essential cellular
functions such as cell growth and survival [40,41]. Aber-
rant regulation of the PI3K/Akt pathway has been dis-
covered in insulin resistant T2DM, leading to enhanced
Akt activity [42]. Activation of Akt increases translation
of cell cycle-associated genes, such as cyclins and cyclin-
dependent kinases. The entry of vascular cells into cell
cycle plays an important role in the pathogenesis of
post-angioplasty restenosis [43]. Immediately after in-
jury, VSMCs leave their resting state and enter the cell
cycle. Arterial injury results in the proliferation and mi-
gration of VSMCs into the intimal layer of the arterial
wall. The contribution of vascular proliferation to the
postangioplasty restenosis is particularly important. In
addition, the proliferative response is also reflected by
PCNA activation, which is a well-accepted marker of cell
proliferation and assists in DNA replication. In a study
of rat aortic VMSCs, Akt signaling is highly activated
following stimulation with platelet-derived growth factor
(PDGF) [44]. Therefore, we established an in vivo rat
carotid artery injury model and determined whether
neointimal SMCs exhibit activated Akt signaling. Cell
proliferation involves changes at the levels of gene tran-
scription and protein translation. In our study, cell pro-
liferation was assessed by using immunohistochemistry
staining for PCNA expression and localization to iden-
tify the actively cycling cells within the media and
intima. The results showed that there were significantly
more PCNA-positive VSMCs in diabetic rats than innon-diabetic rats. Using Western blot analysis we found
that the protein levels of PCNA and p-Akt were both
significantly increased in injured arteries, and were
much higher in diabetic rats. qRT-PCR detection of
PCNA mRNA levels revealed similar results, which was
consistent with the detection of EdU-labeled DNA syn-
thesis. Therefore, we indirectly and strongly confirmed
the accuracy of the EdU incorporation and EdU staining
by detecting PCNA expression with three distinct mo-
lecular biological methods.
To summarize, carotid artery balloon catheter injury
led to cell proliferation, which was validated at the levels
of PCNA and p-Akt protein as well as PCNA mRNA.
And we concluded that EdU incorporation and staining
was useful means for detecting DNA synthesis in the
vascular neointima quickly and efficiently. Additionally,
it only takes less than 2.5 hours for EdU staining, com-
pared to 5 hours and overnight incubation for BrdU
antibody detection method. In this work, we also com-
pared the percentages of EdU-positive cells in GK and
Wistar rats. We discovered that at day 7 after catheter
balloon injury, DNA synthesis in the vascular neointima
could be more readily observed in GK rats than in
Wistar rats by intraperitoneal injections of EdU at a dose
of 100 mg/kg three times. Therefore, it is recommended
that a saturated dose and multiple injections can be used
to obtain reliable and accurate results. In conclusion, we
demonstrate the suitability of EdU incorporation and
staining in GK and Wistar rats, and further probe the
pathological features of diabetes mellitus by observing a
higher amount of DNA synthesis in GK rats.Competing interests
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